June 17, 2019 News by Patricia Inacio, PhD Human Blood-brain Barrier in a Chip, Created in the Lab, May Help Design New Therapies, Study Shows By tweaking stem cells in a laboratory, researchers were able to generate a model of the human blood-brain barrier (BBB) in a chip. The BBB is a highly selective barrier that is damaged in multiple sclerosis (MS), allowing immune cells to reach the central nervous system and damage…
May 15, 2019 News by Marisa Wexler, MS #AANAM – Biogen Offers Update on Development Plans for MS Therapies At the 2019 annual meeting of the American Academy of Neurology (AAN),Ā Multiple Sclerosis News TodayĀ sat down with Bernd Kieseier, MD, global head of multiple sclerosis at Biogen, to discuss the company’s portfolio, latest data, and therapeutic development plans in the field of multiple sclerosis (MS). Kieseier said…
October 27, 2017 News by Patricia Silva, PhD #MSParis2017 ā Real-world Data Leading Way to Personalized Treatment, Biogen Says in Interview Personalized medicine is the future of multiple sclerosis treatment, and research now taking place to collect and analyze data and pinpoint biomarkers will help make possible approaches that ā one day ā will put MS into “complete remission” patient by patient, said Richard Rudick, vice president of Development Sciences at…
May 19, 2017 News by Charles Moore Pilot Study of myMS App, Created to Aid Patients and Research, Starting in US A clinical trial of a smartphone app that helps multiple sclerosis (MS) understand and manageĀ their disease ā and to aid and speed research āĀ is nowĀ recruiting peopleĀ nationwide. Claimed to be the first of its kind, the app, called myMS, is designed to give MS patients quick and easyĀ access toĀ pertinentĀ information, fromĀ clinical evaluations…
February 27, 2017 News by Patricia Silva, PhD #ACTRIMS2017 – Epigenetics’ Role in Myelin Renewal Is Focus of Research The absence of epigenetic factors in myelin-producing oligodendrocyte cells make sure that myelin production is switched off in the adult brain. Targeting these factors may be a way of triggering myelin regeneration in multiple sclerosis (MS), and a step towardĀ personalized medicine for this disease, Dr. Patrizia Casaccia said in aĀ talk…
September 21, 2016 News by Patricia Silva, PhD REAL MS Inviting Patients to Join Research Project Aiming to Promote More Personalized Care Accelerated Cure ProjectĀ is still recruiting forĀ itsĀ iConquerMSĀ project, REAL MS, an alreadyĀ 3,000-strong patient-powered research network for people with multiple sclerosis (MS). REAL MS (ResearchĀ EngagementĀ AboutĀ Life withĀ MultipleĀ Sclerosis)Ā isĀ a longitudinal research study, designed partly by MS patients themselves, intending to answer critical questions about individualĀ experiences of livingĀ with MS from among a large and heterogeneous group…
August 25, 2016 News by Charles Moore Patient-led Study, REAL MS, Invites Adults to Help Advance and Direct MS Research An innovation in multiple sclerosis (MS) research has been launched byĀ the iConquerMSĀ initiative ā a longitudinal, prospective study called “REAL MS,” an acronym for “Research Engagement About Life with Multiple Sclerosis,” with aĀ goal of accelerating research into personalized treatments for MS patients. This type of study collects repeat…
July 23, 2015 News by Maureen Newman Identifying MS Gene Mutations Could Make Personalized Treatment Possible Personalized medicine, often applied to treat cancer, may be possible for patients with multiple sclerosis as well. Certain patients respond differently to certain multiple sclerosis medications, such as interferon-Ī² (IFNĪ²), and researchers at San Raffaele Scientific Institute in Milan may have an answer as to why. The team, led by…